Dr. Reddy's Announces the Launch of Ibandronate Sodium Tablets
News | 02 July 2012
The BONIVA(R) brand and generic had U.S. sales of approximately $486 million for the most recent twelve months ending March 2012 according to IMS Health. Dr. Reddy's Ibandronate sodium tablets in 150 mg are available in cartons of 3 blister packs ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
